2.01 USD
▼-0.11-5.19%
盘后 2.65 0.00%
2026-09-16
市值
$15.48M
市盈率
—
EPS
-4.37
股息率
—
52 周区间
2.01 – 23.43
成交量
53.34K
Beta
1.39
目标价
32.50
52W 低 2.0152W 高 23.43
价格走势
公司简介
Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company’s lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary li...